New pill tested in fight against scarring lung disease
NCT ID NCT05671835
Summary
This study tested a new oral medication called TTI-101 in 100 people with idiopathic pulmonary fibrosis (IPF), a serious lung scarring disease. The main goal was to see if taking the pill daily for 12 weeks was safe and how the body handled the drug. The study also looked for early signs of whether the drug might help slow the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Baylor Scott & White Center for Advanced Heart & Lung Disease
Dallas, Texas, 75246, United States
-
Clinical Trials Center of Middle Tennessee
Franklin, Tennessee, 37067, United States
-
Emory University Hospital
Atlanta, Georgia, 30322, United States
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
Inova Fairfax Medical Campus
Falls Church, Virginia, 22042, United States
-
Loyola University Medical Center
Maywood, Illinois, 60153, United States
-
Metroplex Pulmonary and Sleep Center
McKinney, Texas, 75069, United States
-
New York University Langone Pulmonary and Critical Care Associates
Brooklyn, New York, 10017, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
Penn State Health Milton S. Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
-
Pulmonix
Greensboro, North Carolina, 27403, United States
-
Saint Francis Sleep Allergy and Lung Institute
Clearwater, Florida, 33765, United States
-
Saint Luke's University Hospital - Bethlehem
Bethlehem, Pennsylvania, 18020, United States
-
Salem Chest Specialists
Winston-Salem, North Carolina, 27103-4007, United States
-
Temple University Hospital
Philadelphia, Pennsylvania, 19140, United States
-
The Kirklin Clinic of University of Alabama Birmingham Hospital
Birmingham, Alabama, 35233, United States
-
The Lung Research Center
Chesterfield, Missouri, 63017, United States
-
The Medical University of South Carolina
Charleston, South Carolina, 29425, United States
-
Tulane University School of Medicine
New Orleans, Louisiana, 70112-2600, United States
-
UHealth - University of Miami Health Systems
Miami, Florida, 33125, United States
-
University of California Irvine (UCI) Health
Orange, California, 92868, United States
-
University of California San Diego
La Jolla, California, 92037, United States
-
University of Chicago Medicine
Chicago, Illinois, 60637, United States
-
University of Colorado School of Medicine
Aurora, Colorado, 80045, United States
-
University of Florida
Gainesville, Florida, 32610, United States
-
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242, United States
-
University of Texas Health Science Center at Houston (UT Health)
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.